T1	Participants 16 98	selective stimulation of the immune system in the treatment of carcinoma in humans
T2	Participants 458 533	randomized study of patients with gastric, pancreatic and colorectal cancer
T3	Participants 606 670	randomized study of patients with resectable cancer of the colon
T4	Participants 715 747	patients with malignant melanoma
T5	Participants 823 869	patients with advanced gastrointestinal cancer
